Tedesco F - Search Results

1

Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.

Durigutto P, Sblattero D, Biffi S, De Maso L, Garrovo C, Baj G, Colombo F, Fischetti F, Di Naro AF, Tedesco F, Macor P. Durigutto P, et al. Among authors: tedesco f. Front Immunol. 2017 Sep 6;8:1093. doi: 10.3389/fimmu.2017.01093. eCollection 2017. Front Immunol. 2017. PMID: 28932227 Free PMC article.

2

Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5.

Macor P, Durigutto P, De Maso L, Garrovo C, Biffi S, Cortini A, Fischetti F, Sblattero D, Pitzalis C, Marzari R, Tedesco F. Macor P, et al. Among authors: tedesco f. Arthritis Rheum. 2012 Aug;64(8):2559-67. doi: 10.1002/art.34430. Arthritis Rheum. 2012. PMID: 22334275 Free article.

3

Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.

Durigutto P, Macor P, Ziller F, De Maso L, Fischetti F, Marzari R, Sblattero D, Tedesco F. Durigutto P, et al. Among authors: tedesco f. PLoS One. 2013;8(3):e58696. doi: 10.1371/journal.pone.0058696. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505550 Free PMC article.

4

Complement as a Biological Tool to Control Tumor Growth.

Macor P, Capolla S, Tedesco F. Macor P, et al. Among authors: tedesco f. Front Immunol. 2018 Sep 25;9:2203. doi: 10.3389/fimmu.2018.02203. eCollection 2018. Front Immunol. 2018. PMID: 30319647 Free PMC article. Review.

5

The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies.

Marzari R, Sblattero D, Macor P, Fischetti F, Gennaro R, Marks JD, Bradbury A, Tedesco F. Marzari R, et al. Among authors: tedesco f. Eur J Immunol. 2002 Oct;32(10):2773-82. doi: 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G. Eur J Immunol. 2002. PMID: 12355429 Free article.

6

Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.

Ziller F, Macor P, Bulla R, Sblattero D, Marzari R, Tedesco F. Ziller F, et al. Among authors: tedesco f. Eur J Immunol. 2005 Jul;35(7):2175-83. doi: 10.1002/eji.200425920. Eur J Immunol. 2005. PMID: 15971270 Free article.

7

Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases.

Fischetti F, Tedesco F. Fischetti F, et al. Among authors: tedesco f. Autoimmunity. 2006 Aug;39(5):417-28. doi: 10.1080/08916930600739712. Autoimmunity. 2006. PMID: 16923542 Free article. Review.

8

Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.

Fischetti F, Durigutto P, Macor P, Marzari R, Carretta R, Tedesco F. Fischetti F, et al. Among authors: tedesco f. Arthritis Rheum. 2007 Apr;56(4):1187-97. doi: 10.1002/art.22492. Arthritis Rheum. 2007. PMID: 17393439 Free article.

9

Complement as effector system in cancer immunotherapy.

Macor P, Tedesco F. Macor P, et al. Among authors: tedesco f. Immunol Lett. 2007 Jul 31;111(1):6-13. doi: 10.1016/j.imlet.2007.04.014. Epub 2007 May 29. Immunol Lett. 2007. PMID: 17572509 Review.

10

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

Agostinis C, Durigutto P, Sblattero D, Borghi MO, Grossi C, Guida F, Bulla R, Macor P, Pregnolato F, Meroni PL, Tedesco F. Agostinis C, et al. Among authors: tedesco f. Blood. 2014 May 29;123(22):3478-87. doi: 10.1182/blood-2013-11-537704. Epub 2014 Mar 18. Blood. 2014. PMID: 24642748 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters